NHS should finance HIV treatment PrEP, English High Court rules

The English High Court has today said that National Health Service (NHS) England should finance an important therapy used to treat patients suffering from HIV.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Europe

NHS v Servier: unlawful means tort claim fails, but the long-running saga continues

17 August 2021 The latest episode in the long-running dispute between the NHS and French pharmaceutical company Servier has been marked by a UK Supreme Court judgment of July 2, 2021 on Servier’s application to strike out the NHS’s unlawful means tort claim.

Big Pharma

NHS criticised over HIV drug wait

2 June 2016 National Health Service England has been criticised after announcing its decision that it will not be providing the HIV treatment Truvada, which enables pre-exposure prophylaxis.

More features

Killing the golden goose of US drug innovation (Part II): Drug pricing myths

Former pharma GC brings in-house perspective to McGuireWoods

Sandoz eyes US biosimilar launch as Regeneron settles

Killing the golden goose of US drug innovation (Part I): Follow the money

Buchalter brings in new partner to head up medtech

Trump’s march-in rights threat: Why pharma is rethinking collaborations

UK gets new IP minister following cabinet reshuffle

Barnes & Thornburg reveals five new IP leaders

NHS should finance HIV treatment PrEP, English High Court rules

More on this story

Editor's picks

Editor's picks

More features